跳至主要内容
临床试验/RPCEC00000075
RPCEC00000075尚未招募2 期

Clinical evaluation of the effect anti-inflammatory of the extract of Mangifera indica L. (Vimang®) in patient with diagnosis of Bronchial Asthma.

Center of Pharmaceutical Chemistry0 个研究点目标入组 88 人开始时间: 2009年3月13日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Parallel. Purpose: Treatment

入排标准

年龄范围
20 years 至 45 years(—)
性别
All

入选标准

  • Patients of both sexes, between 20 and 45 years of age, non smokers, who are attended in ambulatory clinics, with diagnosis of persistent moderate asthma that they will be classified by the obstruction degree by spirometry according to Gina 2006. -Patient that are of agreement with participating in the clinical trial -Patients have carried out a Respiratory Functional Test (RFT) with test pre and post bronchial dilator before beginning to take the Vimang® and that it expresses a limitation to the air, reversible or partially reversible flow with bronchial dilator(inhaled Salbutamol).

排除标准

  • - Smoking Patients. - Pregnancy or nursing. - Patients that have normal RFT. - Patient without antecedents of bronchial asthma. - The patient's negative to fulfill the established dose of the Vimang®. - The patient's negative to carry out the protocolized investigations. - Patient that not fulfill with the measures of systematic control: weekly phone calls that include the control of the asthma, besides the biweekly consultation.

研究者

发起方
Center of Pharmaceutical Chemistry

相似试验

Clinical evaluation of the effect anti-inflammatory... | 临床试验